88840-02-2

Basic information

• Product Name: (+)-XESTOSPONGIN A
• Synonyms: XEA;(+)-XESTOSPONGIN A;ARAGUSPONGINE A;[1R-(1R*,4AR*,11R*,12AS*,13R*,16AR*,23R*,24AS*)]-EICOSAHYDRO-5H,17H-1,23:11,13-DIETHANO-2H,14H-[1,11]DIOXACYCLOEICOSINO[2,3-B:12,13-B'] DIPYRIDINE;PQYOPBRFUUEHRC-BXZOIBFVSA-N
• CAS NO: 88840-02-2
• Molecular Formula: C28H50N2O2
• Molecular Weight: 446.71
• Mol File: 88840-02-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (+)-XESTOSPONGIN A(CAS DataBase Reference)
• NIST Chemistry Reference: (+)-XESTOSPONGIN A(88840-02-2)
• EPA Substance Registry System: (+)-XESTOSPONGIN A(88840-02-2)

Safety Data

• Hazardous Substances Data: 88840-02-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(+)-Xestospongin A is used as a research compound for studying the role of IP3 receptor channels in cellular processes. Its ability to modulate calcium signaling pathways makes it a valuable tool in understanding the underlying mechanisms of various diseases and conditions.
Used in Cancer Treatment:
(+)-Xestospongin A is used as a potential therapeutic agent for treating cancer. Its interaction with IP3 receptors can influence cellular processes that are often dysregulated in cancer cells, offering a novel approach to cancer treatment.
Used in Neurodegenerative Disease Research:
(+)-Xestospongin A is used as a research tool to explore its potential in treating neurodegenerative diseases. Given the involvement of calcium dysregulation in such conditions, the compound's ability to modulate IP3 receptor channels could provide insights into new treatment strategies.
Used in Cardiovascular Disorder Research:
(+)-Xestospongin A is used as a research compound to investigate its potential in managing cardiovascular disorders. The modulation of calcium signaling pathways by (+)-Xestospongin A may have implications for the treatment of conditions related to calcium imbalances in the cardiovascular system.